| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/19/2007 | US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 07/19/2007 | US20070167456 Mercaptoimidazoles as ccr2 receptor antagonists |
| 07/19/2007 | US20070167452 Therapeutic amide derivatives |
| 07/19/2007 | US20070167447 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof |
| 07/19/2007 | US20070167442 Such as 1-(1-{3-[4-(ethylsulfonyl)piperazin-1-yl]-3-phenylpropyl}piperidin-4-yl)-5-(methylsulfonyl)-1H-benzimidazole; reductive amination |
| 07/19/2007 | US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 07/19/2007 | US20070167440 Novel pyrrolidine compound and a process for preparing the same |
| 07/19/2007 | US20070167439 N4-(1-tert-Butoxycarbonylazetidin-3-yl)-5-fluoro-N2-(4-morpholinophenyl)-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE ("Fc epsilon RI") and IgG ("Fc gamma RI") antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis |
| 07/19/2007 | US20070167436 Cyclohexyl piperazinyl methanone derivatives |
| 07/19/2007 | US20070167425 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 07/19/2007 | US20070167423 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 07/19/2007 | US20070167410 cyclic oximes useful in treatment or prevention of diseases mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction; 3-{[5-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-5,6,7,8-tetrahydro-naphthalen-2-ylmethyl]-amino}-propionic acid |
| 07/19/2007 | US20070167406 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 07/19/2007 | DE112005002083T5 Lichtemittierende Polymerzusammensetzung und polymere lichtemittierende Vorrichtung The light emitting polymer composition and polymer light emitting device |
| 07/19/2007 | DE102006001574A1 Acylaminoimidazole Acylaminoimidazole |
| 07/19/2007 | CA2635997A1 Morpholino pyrimidine derivatives and their use in therapy |
| 07/19/2007 | CA2635916A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 07/19/2007 | CA2626103A1 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides |
| 07/18/2007 | EP1807418A2 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 07/18/2007 | EP1807414A1 Insecticidal n,n-di(heteroarylalkyl) amine derivatives |
| 07/18/2007 | EP1807410A1 Compounds and compositions useful in the treatment of neoplasia |
| 07/18/2007 | EP1807407A1 Aromatic amides as inhibitors of c-fms kinase |
| 07/18/2007 | EP1807406A2 Inhibitors of c-fms kinase |
| 07/18/2007 | EP1807405A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 07/18/2007 | EP1807404A1 Novel use |
| 07/18/2007 | EP1807387A2 Substituted tetracycline compounds |
| 07/18/2007 | EP1807078A1 Diaminoalkane aspartic protease inhibitors |
| 07/18/2007 | EP1807077A2 Inhibitors of c-fms kinase |
| 07/18/2007 | EP1603912B1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 07/18/2007 | EP1565436A4 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/18/2007 | EP1558598B1 Triazole compounds for the treatment of dysmenorrhoea |
| 07/18/2007 | EP1403251B1 Bis(2-aryl-5-pyridyl) derivative |
| 07/18/2007 | EP1403250B1 Bis(5-aryl-2-pyridyl) derivative |
| 07/18/2007 | EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 07/18/2007 | EP1123291B1 Process for preparing 3-(substituted phenyl)-5-thienyl or furyl)-1,2,4-triazoles and novel intermediates utilized therein |
| 07/18/2007 | CN1326854C Substituted derivatives of aminofuran-2-Y1-acetic acid and aminothien-2-Y1-acetic acid and use thereof for treating migraines and pain |
| 07/18/2007 | CN1326853C Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 07/18/2007 | CN1326852C Benzofuran derivative |
| 07/18/2007 | CN1326848C Aminopyrazole derivatives |
| 07/18/2007 | CN1326839C 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use |
| 07/18/2007 | CN101001850A Amido compounds and their use as pharmaceuticals |
| 07/18/2007 | CN101001845A Substituted quinazolones as anti-cancer agents. |
| 07/18/2007 | CN101001844A Mercaptoimidazoles as CCR2 receptor antagonists |
| 07/18/2007 | CN101001840A Therapeutic compounds: pyridine as scaffold |
| 07/18/2007 | CN101001836A Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/18/2007 | CN101001626A Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor |
| 07/18/2007 | CN100999519A (-) poly thaazoleazine methylsulfonate, its preparation process and use |
| 07/18/2007 | CN100999518A Voriconazole derivate and preparation process thereof |
| 07/17/2007 | US7244853 Dioxanes and uses thereof |
| 07/17/2007 | US7244847 Bactericides |
| 07/17/2007 | US7244846 Substituted benzofuran-2-carboxamides derivatives |
| 07/17/2007 | US7244776 Benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole derivatives; polymer and photographic stabilizers |
| 07/17/2007 | US7244763 Compounds that modulate PPAR activity and methods of preparation |
| 07/17/2007 | US7244757 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
| 07/17/2007 | US7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 07/17/2007 | US7244744 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels |
| 07/17/2007 | US7244743 Non-peptidic BRS-3 agonists |
| 07/17/2007 | US7244738 Urogenital disorders; sexual diosrders; benign prostatic hyperplasia; analgesics |
| 07/17/2007 | US7244735 useful for treating cancer, neurological disorders, autoimmune disorders, and other diseases that are alleviated by protein kinase inhibitors |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/12/2007 | WO2007079470A2 Therapeutic amine-arylsulfonamide conjugate compounds |
| 07/12/2007 | WO2007078251A1 Compounds |
| 07/12/2007 | WO2007077508A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 07/12/2007 | WO2007077005A1 3 , 5-substitγued piperidine compounds as renin inhibitors |
| 07/12/2007 | WO2007076709A1 Tri-substituted 1h-imidazolyl compounds, preparation methods, pharmaceutical compositions and pharmaceutical uses thereof |
| 07/12/2007 | WO2007061948A3 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 07/12/2007 | WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof |
| 07/12/2007 | WO2007027780A3 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/12/2007 | US20070161791 Process for the preparation of terazosin hydrocloride dihydrate |
| 07/12/2007 | US20070161787 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 07/12/2007 | US20070161697 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 07/12/2007 | US20070161689 Indoles having anti-diabetic activity |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161651 Tie-2 modulators and methods of use |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161636 Binding target to photoactive compound then irradiating with xenon arc lamp |
| 07/12/2007 | US20070161626 Substituted Indazoles, Compositions Containing The Same, And The Preparation And Use Thereof |
| 07/12/2007 | US20070161624 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same |
| 07/12/2007 | US20070161620 Isoquinoline compound and pharmaceutical use thereof |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | US20070161026 Regents labeled with energy transfer dyes |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | DE19624590B4 2,2-Difluor-1,3-dioxane, diese enthaltendes flüssigkristallines Medium, deren Verwendung und Zwischenprodukte (1,3-Dioxan-2-thione) 2,2-difluoro-1,3-dioxane, these liquid-crystalline medium containing, their use and intermediates (1,3-dioxan-2-thione) |
| 07/12/2007 | CA2635842A1 Prokineticin 1 receptor antagonists |
| 07/12/2007 | CA2634037A1 2-amino-5-piperidinylimidazolone compounds and use thereof for .beta.-secretase modulation |
| 07/12/2007 | CA2633624A1 3,5-substituted piperidine compounds as renin inhibitors |
| 07/11/2007 | EP1806605A1 Filter and cyanine compound |
| 07/11/2007 | EP1805169A1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses |
| 07/11/2007 | EP1805165A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 07/11/2007 | EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 07/11/2007 | EP1805155A1 Thrombopoietin activity modulating compounds and methods |
| 07/11/2007 | EP1805147A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1408961B1 2 pyrrolidone derivatives as prostanoid agonists |
| 07/11/2007 | EP1355886B1 Fused heterocyclic compounds |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |